Significantly more adolescent patients receiving baricitinib had hair regrowth compared with patients receiving placebo.

2022 — Researchers have discovered that a signaling molecule called SCUBE3 potently stimulates hair growth and may offer a therapeutic treatment for androgenetic alopecia, a common form of hair ...

Incyte is preparing to take an oral JAK inhibitor into phase 3 trials for the skin depigmentation disease vitiligo, after reporting mid-stage data showing efficacy in patients with facial and full ...

"I lost all my hair 10 and a half years ago. I have what's called Alopecia Universalis, and that's when you lose your hair... from head to toe," said the boutique's owner, Lori Powell, on Friday.

Dermatitis. 2005;16(1):6-21.